• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性皮肤卟啉病和肝红细胞生成性卟啉病

[Porphyria cutanea tarda and hepatoerythropoietic porphyria].

作者信息

Nonaka S, Takamiyagi A

机构信息

Department of Dermatology, Faculty of Medicine, University of the Ryukyus.

出版信息

Nihon Rinsho. 1995 Jun;53(6):1427-32.

PMID:7616658
Abstract

Porphyria cutanea tarda (PCT) is induced by an enzyme deficiency of hepatic uroporphyrinogen decarboxylase activity. As the result of this enzyme deficiency, uroporphyrin and coproporphyrin accumulate to the skin and other organs. These porphyrins are excreted into urine because of their easy solubility in water. Exposure to the sunlight of the porphyrin-rich skin induces cutaneous changes. Porphyria cutanea tarda develops mainly in middle-aged males, sometimes in females. Ethylalcohol, estrogenic hormones, and hemodialysis are reported as provocative factors. Hyperpigmentation on exposed areas, skin fragility, vesicles and erosions are common in PCT. Histopathologically, subepidermal bulla is a characteristic finding in PCT. PAS positive materials are also prominent around the small blood vessels in the dermis and dermo-epidermal junctions. Hepatoerythropoietic porphyria (HEP) is usually manifest in early childhood with dark urine and reveals severe cutaneous photosensitivity. This disease is a homozygous form of type II PCT.

摘要

迟发性皮肤卟啉症(PCT)由肝脏尿卟啉原脱羧酶活性的酶缺乏引起。由于这种酶缺乏,尿卟啉和粪卟啉在皮肤和其他器官中积累。这些卟啉因其易溶于水而排泄到尿液中。富含卟啉的皮肤暴露于阳光下会引起皮肤变化。迟发性皮肤卟啉症主要发生在中年男性,有时也发生在女性。乙醇、雌激素和血液透析被报道为诱发因素。暴露部位色素沉着、皮肤脆弱、水疱和糜烂在PCT中很常见。组织病理学上,表皮下大疱是PCT的特征性表现。真皮和真皮-表皮交界处的小血管周围PAS阳性物质也很突出。肝红细胞生成性卟啉症(HEP)通常在幼儿期表现为尿液颜色深,并表现出严重的皮肤光敏感性。这种疾病是II型PCT的纯合形式。

相似文献

1
[Porphyria cutanea tarda and hepatoerythropoietic porphyria].迟发性皮肤卟啉病和肝红细胞生成性卟啉病
Nihon Rinsho. 1995 Jun;53(6):1427-32.
2
Porphyria cutanea tarda as the most common porphyria.迟发性皮肤卟啉症是最常见的卟啉症。
Acta Dermatovenerol Croat. 2007;15(4):254-63.
3
Mutations in familial porphyria cutanea tarda: two novel and two previously described for hepatoerythropoietic porphyria.家族性迟发性皮肤卟啉症中的突变:两种新发现的突变以及两种先前已描述的肝红细胞生成性卟啉症相关突变。
Hum Mutat. 2000 Sep;16(3):269-70. doi: 10.1002/1098-1004(200009)16:3<269::AID-HUMU12>3.0.CO;2-#.
4
A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.人类尿卟啉原脱羧酶基因突变(G281E)导致肝红细胞生成性卟啉病和显性家族性迟发性皮肤卟啉病:对西班牙患者的生化和遗传学研究
J Invest Dermatol. 1995 Apr;104(4):500-2. doi: 10.1111/1523-1747.ep12605953.
5
[Porphyria in dermatology].[皮肤病学中的卟啉病]
Nihon Rinsho. 1995 Jun;53(6):1449-55.
6
Porphyria cutanea tarda--when skin meets liver.迟发性皮肤卟啉病——皮肤与肝脏的相遇。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):735-45. doi: 10.1016/j.bpg.2010.07.002.
7
Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.迟发性皮肤卟啉病和肝红细胞生成性卟啉病:19 种新型尿卟啉原 III 脱羧酶突变的鉴定。
Mol Genet Metab. 2019 Nov;128(3):363-366. doi: 10.1016/j.ymgme.2018.11.013. Epub 2018 Nov 28.
8
Hepatoerythropoietic porphyria: relationship with familial porphyria cutanea tarda.肝红细胞生成性卟啉病:与迟发性皮肤卟啉病的关系。
Dermatology. 1996;193(4):332-5. doi: 10.1159/000246284.
9
Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern.肝红细胞生成性卟啉病:尿卟啉原脱羧酶(UROD)基因中的错义突变与轻度疾病及异常的卟啉排泄模式相关。
Br J Dermatol. 2004 Oct;151(4):920-3. doi: 10.1111/j.1365-2133.2004.06101.x.
10
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.迟发性皮肤卟啉症患者的肝脏尿卟啉原脱羧酶活性:丙型病毒感染的影响。
Hepatology. 1998 Feb;27(2):584-9. doi: 10.1002/hep.510270237.